THERAPEUTIC REVOLUTION: to defeat the inevitable and make you healthier again

The exponential increase in the number of inquiries I have been receiving about Ozempic, Mounjaro, and other GLP-1 receptor agonists (GLP-1 RA) formulations, encouraged me to write this book, to provide insights into the beneficial effects, side effects and potential risks of these innovative molecules. When chronic degenerative diseases progress despite efforts to follow the principles extensively discussed in my previous book, The Healthspan Code, this new class of molecules could represent a possible ally. They have shown significant potential to act as a powerful ally to The Healthspan Code, temporarily halting the progression toward the “inevitable” and offering another opportunity to recommit to the Healthspan pillars. These principles emphasize an ecosystem-based approach, where no single solution or magic remedy is sufficient on its own. It is crucial, therefore, to focus not only on curing diseases but also on their prevention, not just to avert the progression of risk factors toward the development of chronic degenerative diseases, but also to prevent disease recurrence after an initially successful cure, such as an islet cell transplant for people with diabetes. Recent findings highlight the wide-ranging benefits of GLP-1 RA, from preventing and slowing disease progression to mitigating risks associated with insulin resistance, excess weight, diabetes, cardiovascular and kidney diseases, neurodegenerative and autoimmune disorders, chronic inflammation, osteoarticular conditions, and even viral illnesses like COVID-19. Notably, emerging data revealed that GLP-1 receptor agonists, specifically semaglutide, lowered the risk of death from all causes, including cardiovascular conditions and COVID-19. Additionally, a groundbreaking study demonstrated that tirzepatide determined a significant weight loss (up to almost 21%) as well as a 93% reduction in the risk of developing type 2 diabetes. This is a remarkable achievement compared to earlier prevention rates of up to 58% with interventions like diet, exercise, and metformin. While these results are promising, GLP-1 RA benefits may be associated with their continuous use, unless an initially beneficial treatment is integrated with a renewed adherence to a Healthspan ecosystem. These treatments can indeed enhance health in several conditions, but without adherence to the principles outlined in The Healthspan Code, people risk regaining weight and resuming disease progression after discontinuing the medications. Importantly, like for any other treatment (e.g., insulin for diabetes), if we really want to democratize health and make a global impact, these drugs must become affordable, not only for those with insurance or financial means, but also for all those in need. Currently, their cost is sometime higher than $1,000/month while a recent important study concluded that drug companies could sell GLP-1 RA for $1 to $5 a month, depending on the production volume, and still make a profit. Importantly, the current pricing is economically unsustainable, not only for most individuals, but also for healthcare systems, if we consider that one in three Americans has prediabetes, and obesity has reached epidemic levels worldwide. In summary, primary prevention and the prevention of disease recurrence share similar strategies, all aimed at extending lifespan in good physical and mental health (Healthspan). Achieving this goal requires a holistic approach encompassing nutrition, healthy lifestyle, protective molecules, and environmental considerations. We must always remember that a healthy lifespan can only thrive on a healthy and peaceful planet, and I hope this book serves as a valuable resource to foster greater collective awareness of the need to address one of the greatest challenges of our time: improving human health and safeguarding our planet’s future.
ASIN: B0DSV1PRQG
VSKU: BVV.B0DSV1PRQG.G
Condition: Good
Author/Artist:Ricordi, Dr. Camillo|Battelino, Dr. Tadej|Skyler, Dr. Jay|Infante, Dr. Marco
Binding: Paperback
Note: Any images shown are stock photographs and product may differ from what is shown.
Condition Notes: The item shows wear from consistent use, but it remains in good condition and works perfectly. All pages and cover are intact including the dust cover, if applicable . Spine may show signs of wear. Pages may include limited notes and highlighting. May NOT include discs, access code or other supplemental materials.